Innovation
1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 39 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
R&D of new and biosimilar MAbs in the areas of oncology, infectious diseases, and immune disorders
1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 39 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |